Internal Medicine, Hematology & Oncology · West Orange, NJ
NPI
1124089719
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
354 Main St
West Orange, NJ, 07052
Phone (973) 731-2201
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
5,307 services
Medicare patients, 2024
93
Average age 77
Drug cost, 2024
$1.9M
585 prescriptions
Company payments, 2024
$99.95
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trevor Layne was code 99232 (hospital e&m - subsequent), 544 times for 47 patients. In total Trevor Layne billed 5,307 services in 34 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 544 | 47 | $65.89 | $36K |
| 99214 Office E&M - Established | Office | 216 | 44 | $102.17 | $22K |
| 99213 Office E&M - Established | Office | 50 | 29 | $79.45 | $3,973 |
| 99222 Hospital E&M - Initial | Facility | 38 | 34 | $104.49 | $3,971 |
By year: 2022 $168K for 12,502 services; 2023 $166K for 13,954 services; 2024 $177K for 5,307 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 14 | $2.98 | $47.64 |
Medicare prescription drug claims, 2024
In 2024, the drug Trevor Layne prescribed most often to Medicare patients was Eliquis (Apixaban), with 77 prescriptions and refills. In total Trevor Layne wrote 585 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 77 | 110 | 18 | $58K |
| Hydroxyurea Generic | 39 | 58 | Under 11 | $705 |
| Procrit Epoetin Alfa | 35 | 35 | Under 11 | $144K |
| Prednisone Generic | 30 | 33 | Under 11 | $142 |
| Anastrozole Generic | 27 | 70 | Under 11 | $504 |
| Imfinzi Durvalumab | 24 | 24 | Under 11 | $309K |
| Atorvastatin Calcium Generic | 23 | 65 | Under 11 | $233 |
| Revlimid Lenalidomide | 20 | 20 | Under 11 | $364K |
| Ondansetron Odt Ondansetron | 18 | 18 | Under 11 | $251 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 16 | 16 | Under 11 | $416 |
| Lenalidomide Generic | 15 | 15 | Under 11 | $195K |
| Azithromycin Generic | 15 | 15 | 12 | $37.83 |
| Darzalex Daratumumab | 15 | 15 | Under 11 | $164K |
| Pantoprazole Sodium Generic | 14 | 25 | Under 11 | $138 |
| Gabapentin Generic | 14 | 15 | Under 11 | $147 |
Brand drugs: 239 claims; generic drugs: 346 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Trevor Layne $99.95 ($99.95 in general payments such as food, travel and fees) from 1 company. The largest payer was Incyte Corporation with $99.95.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 1 | $99.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.